Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Phase II trial of Auxora in patients with acute pancreatitis and accompanying SIRS and hypoxemia

June 22, 2021

Pfizer studies PF-07202954 in phase I healthy volunteer trial for NAFLD

June 21, 2021

Amgen synthesizes new fatty acid desaturase 1 inhibitors

June 18, 2021

Topline data from phase I study of NASH drug candidate ASC-42

June 17, 2021

Positive topline data from phase IIa LIFT study of TERN-101 in NASH

June 15, 2021

Albiero Pharma synthesizes new ASBT and/or NTCP inhibitors

June 14, 2021

Enrollment opens in phase IIa study of FM-101 for NAFLD and NASH

June 11, 2021

Novel synthetic biotic to promote mucosal healing for treatment of IBD

June 3, 2021

MiR-30c mimics ameliorate liver fibrosis in vivo

June 2, 2021

GPR55 promotes NASH development through ACC activation

June 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.